| Literature DB >> 33707425 |
Aaron Cravens1, Osman K Jamil2, Deze Kong1, Jonathan T Sockolosky3, Christina D Smolke4,5.
Abstract
Random mutagenesis is a technique used to generate diversity and engineer biological systems. In vivo random mutagenesis generates diversity directly in a host organism, enabling applications such as lineage tracing, continuous evolution, and protein engineering. Here we describe TRIDENT (TaRgeted In vivo Diversification ENabled by T7 RNAP), a platform for targeted, continual, and inducible diversification at genes of interest at mutation rates one-million fold higher than natural genomic error rates. TRIDENT targets mutagenic enzymes to precise genetic loci by fusion to T7 RNA polymerase, resulting in mutation windows following a mutation targeting T7 promoter. Mutational diversity is tuned by DNA repair factors localized to sites of deaminase-driven mutation, enabling sustained mutation of all four DNA nucleotides at rates greater than 10-4 mutations per bp. We show TRIDENT can be applied to routine in vivo mutagenesis applications by evolving a red-shifted fluorescent protein and drug-resistant mutants of an essential enzyme.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33707425 DOI: 10.1038/s41467-021-21876-z
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919